NASDAQ · SSYS

Stratasys Inc. (ISRAEL)

$8.03 +$0.03 (+0.37%) 1D After hours

Key Metrics

$694.51M
Market cap
P/E · TTM
$551.10M
Revenue · TTM
−$104.29M
Net income
EPS · TTM $-1,514.22
Dividend yield
Free cash flow −$6.97M
Beta · 1Y 2.07
EBITDA · TTM −$51.79M
Gross margin 41.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved -11.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Mar 30
    From its Feb 9 high, the share price fell 35%.

    Peak close $11.36 on Feb 9; trough close $7.42 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -35%
  • Feb 6
    The stock moved +10.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$694.51M
Enterprise value
Shares outstanding86.8M
52-wk range$7.34 – $12.81
Avg volume · 20D879.8K
Net cash
Book value / share$12,238.91
ExchangeNASDAQ
About Stratasys Inc. (ISRAEL)
IPO dateOct 28, 1994
Employees1757

Stratasys Ltd offers polymer-based 3D printing solutions for designers, engineers, manufacturers, dental and medical professionals, and others.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.26
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 41.2%
Operating -13.2%
Net -18.9%
FCF -1.3%
ROE / ROIC -12.7% · -10.2%

Financial Health

Current ratio3.57
Quick ratio2.68
Debt / equity
Debt / EBITDA
Net cash
Working capital$418.94M

Cash Flow · TTM

Operating CF $15.14M
Capex −$22.11M
Free cash flow −$6.97M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-0.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2023-09-30 · computed by TickerWolf from SEC filings